Cerebral embolism complicating Libman-Sacks endocarditis - Full recovery using recombinant tissue plasminogen activator [5]

Journal of Rheumatology

Volumn 29, Issue 9, 2002, Pages 2022-2024

  Joven, Beatriz ^a   Mellor Pita, Susana ^a   D'Cruz, David ^a   Sharief, Mohammed ^a   Khamashta, Munther ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; BRAIN EMBOLISM; CASE REPORT; CLINICAL EXAMINATION; ENDOCARDITIS; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; SYMPTOMATOLOGY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL EMBOLISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECOVERY OF FUNCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0036733625     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. A hitherto undescribed form of valvular and mural endocarditis
2. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus
3. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus
4. Cardiac abnormalities in systemic lupus erythematosus: Association with raised anticardiolipin antibodies
5. Cardiovascular involvement in systemic lupus erythematosus
6. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant
7. Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients
8. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus
9. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus
10. Cardiac disease in systemic lupus erythematosus: Prospective study of 70 patients
11. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies
12. Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience
13. Antithrombotic and thrombolytic therapy for ischemic stroke
14. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke